Marpai, Inc. Purchase Agreements
8 Contracts & Agreements
- Form of Securities Purchase Agreement executed by and between Marpai Health Inc. and investor parties thereto, dated August 28, 2024 (Filed With SEC on September 3, 2024)
- Securities Purchase Agreement, dated April 15, 2024, by and among Marpai, Inc., its subsidiaries named therein, the purchasers named therein, and JGB Collateral, LLC (Filed With SEC on April 17, 2024)
- Securities Purchase Agreement executed by and between Marpai Health Inc. and HillCour Investment Fund, LLC, dated March 7, 2024 (Filed With SEC on March 8, 2024)
- Amendment No. 1 to Purchase Agreement, by and between Marpai, Inc. and AXA S.A., a French socit anonyme, dated February 7, 2024 (Filed With SEC on February 8, 2024)
- Securities Purchase Agreement executed by and between Marpai Health Inc., HillCour Investment Fund, LLC, Yaron Eitan and Robert Pons, dated January 16, 2024 (Filed With SEC on January 17, 2024)
- Securities Purchase Agreement executed by and between Marpai Health Inc. and HillCour Investment Fund, LLC, dated December 14, 2023 (Filed With SEC on December 15, 2023)
- Purchase Agreement by and between X.L. America, Inc., Seaview Re Holdings Inc., AXA S.A. and Marpai, Inc. dated as of August 4, 2022 for the purchase of Maestro Health, LLC (Filed With SEC on August 9, 2022)
- Asset Purchase Agreementbetween SQN Venture Income Fund, L.P. and CITTA Inc. dated August 12, 2019 (Filed With SEC on July 20, 2021)